drugset / Trial / NCT01396135
A Phase 1 Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese Subjects
RandomizedParallel-groupDouble-blindBasic science
Summary
This Phase 1 study is the first clinical trial to be conducted in Japanese subjects. The pharmacokinetics, safety and tolerability of single and multiple doses of CP-601,927 will be evaluated in Japanese, healthy, non-smoking subjects.
Timeline
- Start
- 2011-08-26
- Primary completion
- 2011-10-29
- Completion
- 2011-10-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CP-601,927 | Small molecule | 1 mg | Oral |
| Subject | CP-601,927 | Small molecule | 2 mg | Oral |
| Subject | CP-601,927 | Small molecule | 3 mg | Oral |
Indications
No indication recorded.